Health Care

Eli Lilly and Company stock analysis: 38.6% revenue growth, a two-year high and a 46.15 P/E. See how the scores lead to a Hold signal.

UnitedHealth Group Incorporated stock analysis: a 7.4% free cash flow yield and 22.74 P/E, but revenue is down 0.4%. See the Hold signal explained.

Relay Therapeutics, Inc. stock analysis: $117M cash burn, $10M revenue and a two-year high. See what the Quality, Growth and Opportunity scores show.

Parabilis Medicines, Inc. stock analysis: a $3.37B pre-revenue biotech with strong liquidity, deep losses and no model signal. See the risks.

Molina Healthcare Inc stock analysis: revenue down 3.5% (TTM), a 1.0% operating margin and a Sell signal from our scoring model. See the full data.

Zoetis Inc. stock analysis: elite margins, a 13.1 P/E and stalled growth. See how the Quality, Growth and Opportunity scores add up to a Buy signal.

Legend Biotech stock analysis: revenue up 51.9% and a Growth score of 93, but a net loss and thin cash flow keep our scoring model at Hold.